No abstract available
MeSH terms
-
Antigens, CD19 / immunology*
-
Drug Approval
-
Humans
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Receptors, Antigen, T-Cell / immunology*
-
Receptors, Antigen, T-Cell / therapeutic use
-
United States
-
United States Food and Drug Administration
Substances
-
Antigens, CD19
-
Receptors, Antigen, T-Cell
-
tisagenlecleucel